Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Research analysts at Wedbush dropped their Q2 2024 EPS estimates for Cresco Labs in Read More
November 17, 2024
Medicinal cannabis patients will be allowed behind the wheel as part of a new government study to test their impairment. Read More
The armed forces of the Democratic Republic of the Congo (DRC) said on Sunday that a coup attempt in the Read More
The Biden administration’s push to reclassify marijuana as a less-dangerous drug is going forward without the support of the Read More
Akanda Announces Closing of Subsequent Registered Direct Offering London, United Kingdom–(Newsfile Corp. – May 20, 2024) – Akanda Corp. (NASDAQ: AKAN) (“Akanda” or Read More
(Reuters) – Security forces thwarted a coup attempt in the Democratic Republic of Congo on Sunday in which armed men targeted Read More
Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Equities research analysts at Roth Capital issued their FY2025 earnings per share estimates Read More
Needham & Company LLC reaffirmed their hold rating on shares of Cresco Labs (OTCMKTS:CRLBF – Free Report) in a research Read More
Organigram (TSE:OGI – Free Report) had its price target reduced by Jefferies Financial Group from C$4.40 to C$4.35 in a Read More
Cresco Labs (OTCMKTS:CRLBF – Free Report) had its price objective upped by Wedbush from $2.50 to $3.00 in a research note issued Read More